192 related articles for article (PubMed ID: 16155734)
1. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.
Ellis JA; Panagiotopoulos S; Akdeniz A; Jerums G; Harrap SB
J Hum Genet; 2005; 50(10):534-537. PubMed ID: 16155734
[TBL] [Abstract][Full Text] [Related]
2. Profiles of 5α-Reduced Androgens in Humans and Eels: 5α-Dihydrotestosterone and 11-Ketodihydrotestosterone Are Active Androgens Produced in Eel Gonads.
Yazawa T; Inaba H; Imamichi Y; Sekiguchi T; Uwada J; Islam MS; Orisaka M; Mikami D; Ida T; Sato T; Miyashiro Y; Takahashi S; Khan MRI; Suzuki N; Umezawa A; Kitano T
Front Endocrinol (Lausanne); 2021; 12():657360. PubMed ID: 33833737
[TBL] [Abstract][Full Text] [Related]
3. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
[TBL] [Abstract][Full Text] [Related]
4. Steroid 5alpha-reductase 1 polymorphisms and testosterone/dihydrotestosterone ratio in male patients with hypospadias.
Tria A; Hiort O; Sinnecker GH
Horm Res; 2004; 61(4):180-3. PubMed ID: 14739525
[TBL] [Abstract][Full Text] [Related]
5. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
Li J; Ding Z; Wang Z; Lu JF; Maity SN; Navone NM; Logothetis CJ; Mills GB; Kim J
PLoS One; 2011; 6(12):e28840. PubMed ID: 22194926
[TBL] [Abstract][Full Text] [Related]
6. Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice.
Windahl SH; Andersson N; Börjesson AE; Swanson C; Svensson J; Movérare-Skrtic S; Sjögren K; Shao R; Lagerquist MK; Ohlsson C
PLoS One; 2011; 6(6):e21402. PubMed ID: 21731732
[TBL] [Abstract][Full Text] [Related]
7. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
8. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
9. 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation.
Schiffer L; Arlt W; Storbeck KH
J Steroid Biochem Mol Biol; 2024 Jul; 241():106516. PubMed ID: 38582131
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
[TBL] [Abstract][Full Text] [Related]
11. A role for steroid 5 alpha-reductase 1 in vascular remodeling during endometrial decidualization.
Shaw IW; Kirkwood PM; Rebourcet D; Cousins FL; Ainslie RJ; Livingstone DEW; Smith LB; Saunders PTK; Gibson DA
Front Endocrinol (Lausanne); 2022; 13():1027164. PubMed ID: 36465608
[TBL] [Abstract][Full Text] [Related]
12. Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer.
Audet-Walsh É; Yee T; Tam IS; Giguère V
Endocrinology; 2017 Apr; 158(4):1015-1021. PubMed ID: 28324044
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of steroid 5-alpha-reductase type I (SRD5A1) gene are associated to peripheral arterial disease.
Signorelli SS; Barresi V; Musso N; Anzaldi M; Croce E; Fiore V; Condorelli DF
J Endocrinol Invest; 2008 Dec; 31(12):1092-7. PubMed ID: 19246976
[TBL] [Abstract][Full Text] [Related]
14. Associations of SRD5A1 gene variants and testosterone with dysglycemia: Henan Rural Cohort study.
Liu X; Wei D; Jiang J; Liu X; Tu R; Luo Z; Wang Y; Dong X; Qiao D; Shen F; Li R; Wang Y; Jin Y; Yu S; Huo W; Li L; Li W; Jing T; Wang C; Mao Z
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):599-607. PubMed ID: 31870594
[TBL] [Abstract][Full Text] [Related]
15. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
[TBL] [Abstract][Full Text] [Related]
16. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
Allen NE; Forrest MS; Key TJ
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues.
Fouad Mansour M; Pelletier M; Tchernof A
J Steroid Biochem Mol Biol; 2016 Jul; 161():45-53. PubMed ID: 26855069
[TBL] [Abstract][Full Text] [Related]
18. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
[TBL] [Abstract][Full Text] [Related]
19. Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men.
Allen NE; Reichardt JK; Nguyen H; Key TJ
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):578-81. PubMed ID: 12815006
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
